Age- Matched Comparison of Children Hospitalized for 2009 Pandemic H1N1 Influenza with Those Hospitalized for Seasonal H1N1 and H3N2 by Chiu, Susan S. et al.
Age- Matched Comparison of Children Hospitalized for
2009 Pandemic H1N1 Influenza with Those Hospitalized
for Seasonal H1N1 and H3N2
Susan S. Chiu
1*, Kwok-Hung Chan
2, Wilfred H. S. Wong
1, Eunice L. Y. Chan
1, J. S. M. Peiris
2,3
1Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Pokfulam, Hong Kong, 2Department of Microbiology, The University of Hong Kong,
Pokfulam, Hong Kong, 3Hong Kong University Pasteur Research Centre, Pokfulam, Hong Kong
Abstract
Background: A wide spectrum of clinical manifestation ranging from deaths to a mild course of disease has been reported
in children infected with the 2009 pandemic H1N1 (pH1N1) influenza.
Methodology/Major Findings: We conducted an age-matched control study comparing children hospitalized for pH1N1
with historic controls infected with seasonal H1N1 and H3N2 influenza to correct for the effect of age on disease
susceptibility and clinical manifestations. We also compared children with pH1N1 to children concurrently admitted for
seasonal influenza during the pandemic period to adjust for differences in health-seeking behavior during the pandemic or
other potential bias associated with historic controls. There was no death or intensive care admission. Children with pH1N1
were more likely to have at least one risk condition for influenza, an underlying chronic pulmonary condition, more likely to
have asthma exacerbation and to be treated with oseltamivir. There was no difference in other aspects of the clinical course
or outcome.
Conclusion: Disease manifestation of children hospitalized for pH1N1 infection was mild in our patient population.
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Introduction
Pandemic H1N1 (pH1N1) influenza emerged in March 2009 in
Mexico. [1,2] There have been case series reports of severe disease
and deaths, including that in children. [1–9]. However, there are
also reports of a wide spectrum of clinical manifestation including
a mild course of disease. [10–15]. Recently, a few studies
compared pH1N1 with seasonal influenza infection. One study
showed that children with pH1N1 presented with more lower
respiratory infections and gastrointestinal symptoms than children
with seasonal influenza in the previous 2 years. [16]. Two studies
using different cohorts for comparison showed that pH1N1 did not
appear to cause more severe disease than seasonal influenza A in
children. [17,18]. However, none of these studies were age-
matched and children of different age groups might have different
susceptibility and disease manifestations. We therefore sought to
document the characteristics and manifestations of children
admitted to Queen Mary Hospital, Hong Kong with laboratory-
confirmed pH1N1 and compared them to age-matched historic
controls admitted to the same hospital with seasonal influenza. We
also compared children hospitalized with pH1N1 with those
concurrently admitted for seasonal influenza to correct for altered
health seeking behavior during a pandemic and other potential
biases associated with historic controls.
Materials and Methods
Queen Mary Hospital is a tertiary-care public hospital and is
the teaching hospital of The University of Hong Kong. The
pediatric general ward and intensive care unit take admission from
its emergency department as well as referrals from other hospitals
and clinics. We have been routinely performing virologic testing
on nasopharyngeal aspirate (NPA) samples on all children
admitted with fever and signs of acute respiratory symptoms such
as rhinitis, cough or sorethroat since 1995. We conducted a
retrospective study by retrieving the medical record of all patients
,18 years of age hospitalized for pH1N1 in the first 3 months of
the pandemic from 1 July 2009 through 30 September 2009 and
that of age- matched controls hospitalized in our hospital for
seasonal influenza H1N1 and H3N2 in the preceding years in a
1:1 ratio. These age-matched controls were selected patients from
the database in the Department of Microbiology according to
admission dates closest to the study period, matched to the closest
year of age. To overcome the potential bias of comparison with
historic controls, we also performed comparisons of children
admitted with pH1N1 with children admitted for seasonal
influenza during the pandemic period. Parameters collected
included underlying conditions deemed high risk of influenza
complications, discharge diagnoses, duration of hospitalization,
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and chest x ray abnormalities and oseltamivir and antibiotic use.
The study protocol was approved by the joint institutional review
board of the University of Hong Kong and Queen Mary Hospital
(Hong Kong) which waived the written consent. Written consent
was not felt to be needed since virologic testing was a routine
diagnostic procedure and patient information saved at the study
database was delinked from individual patient identification. From
the emergence of the pandemic until the 1
st of July, Hong Kong
implemented a containment and mitigation strategy where all
patients confirmed to be infected with pH1N1 were hospitalized
and discharged according to isolation and infection control
measures, regardless of clinical indication. Starting June 29, 2009,
when pH1N1 became more widely circulating in the community,
the Department of Health and the Hospital Authority of Hong
Kong implemented an adjustment of policy to hospitalize patients
on the basis of clinical need rather than recommend mandatory
hospitalization of all infected individuals [19]. Therefore, patients
for this study were recruited from the 1
st July onwards to avoid
patients admitted for public health containment purposes irrespec-
tive of clinical need. Children were hospitalized either because 1)
their respiratory infection symptoms warranted admission through
the Emergency Department or 2) their respiratory symptoms led to
pH1N1 testing in the outpatient clinics and admitted when they
testedpositive. Allhospitalized children with virologically diagnosed
pH1N1 or seasonal influenza were included in the analysis.
NPA were tested for Influenza A and B by direct antigen
detection and virus culture in all recruited patients. All the NPA
samples were tested for influenza virus type A and B and subtyped
as pH1N1, seasonal H3N2 and seasonal H1N1 viruses by RT-
PCR as previously described [20–21,22].
Comparisons between children with pandemic influenza A
H1N1, seasonal H1N1 and H3N2, as well as that between those
with pH1N1 and concurrently admitted seasonal influenza cases
during the pandemic period were made. Children with pH1N1
were also compared to all control children admitted for seasonal
influenza. Paired t-test was used to detect the difference of
continuous variables such as maximum temperature, length of
hospital stay between pairs of observation. McNemar’s test was
used to detect the agreement of the paired proportion in
categorical risk factors. Unpaired t-test was used for comparison
when there was a missing continuous variable. Chi-square test was
used to detect the association of abnormal chest xray, lymphocyte
and neutrophil counts between groups when there were missing
data in these variables. A p value less than 0.05 was considered
statistically significant. Post-hoc analysis demonstrated that 80
subjects per group had 80% power of detecting a 5% difference
with a significance level of 0.05.
Results
Ninety-nine children with a median age of 5.7 (0.4–17.4) years
were hospitalized and confirmed to have pH1N1 infection in the 2
study months, with a male to female ratio of 1.25:1. Since these
children were not admitted for mandatory isolation under the
containment and early mitigation phases, only 19.2% were known
to have pH1N1 on admission, the others were admitted for
respiratory symptoms and diagnosed as pH1N1 after admission.
During the same time, 37 children with a median age of 2.7 years
(6 days to11 years) were hospitalized for seasonal influenza (4 with
seasonal H1N1 and 33 with H3N2). The mean age of children
with seasonal influenza were younger than those with pH1N1:
mean age of 3.662.9 years compared to that of 6.664.8 years in
those with pH1N1 (p=0.0005).
Patients admitted for pH1N1 infection were more likely to have at
least one high risk condition for influenza. (Table 1). There was no
difference in clinical diagnosis between the 4 groups of patients with
the exception that asthma exacerbation and acute otitis media were
diagnosed more often in children admitted for pH1N1 than children
with seasonal influenza. (Table 2). Pneumonia was diagnosed in
11.1% of patients infected with pH1N1, 10 % and 11% in age
matched children with seasonal H1N1 or H3N2 respectively, and in
5.4% in concurrently admitted children with seasonal influenza
(p=NS) and 5.1%, 0%, 3% and 0% of them respectively were
thought to have bacterial pneumonia (p=NS). There was no death
or intensive care admission in any child in this study.
The mean maximum recorded temperature of patients infected
with pH1N1 was statistically significantly lower than those infected
with seasonal H1N1 and H3N2. Although statistically significant,
the clinical significance of mean maximal recorded temperatures
of 39.5 vs. 39.7 may be questionable (Table 3) A significant
proportion of children infected with any influenza A infection were
lymphopenic with no significant difference between pandemic and
seasonal influenza. Duration of hospitalization of children with
pH1N1 (mean of 3.462.1 days) was no different to those
concurrently admitted with seasonal influenza but was significantly
longer than the 2.561.1 days of those in the age matched group
with seasonal H1N1 (p=0.0002). However, only 9.1% of patients
with pH1N1 were still febrile at discharge, as compared to 23.2%
of those with seasonal pH1N1 (p=0.0176) and 21.2% with H3N2
(p=0.031).
Almost half of the patients admitted for pH1N1 were treated
with a full course of oseltamivir, significantly more so that those
with seasonal influenza admitted concurrently or in the age
matched control group (Table 3). The increased use of oseltamivir
in pH1N1 infected children was influenced more by concerns and
guidelines of clinical care arising as a result of the pandemic, i.e.
patients with underlying health conditions should have antiviral
therapy, in contrast to the practice in previous years. We
compared pH1N1 infected children who received oseltamivir
with similarly infected children who did not. pH1N1 infected
children treated with oseltamivir were older with a mean age of
7.864.7 years vs. 5.364.7 years (p=0.0095), had a longer
duration of hospitalization of 462.4 days vs. 2.761.4 days
(p=0.0014), and were more likely to have pneumonia: 20.4% vs.
2% (p=0.0095) when compared to those who did not receive
oseltamivir. There was a trend that patients who received
oseltamivir were more likely to have one or more high risk
conditions. Three of 49 (6.1%) of children who received
oseltamivir for pH1N1 had adverse events: one each with
vomiting, urticaria and behavioral problems. The child with
behavioral changes was a 6 year old boy with moderate asthma
attack and discharged from our hospital on oseltamivir. After
taking 4 doses of oseltamivir, he became irritable and exhibited
some violent acts including pointing a knife at his own neck and
hitting his mother. When brought back to the hospital he was alert
and conscious but uncooperative for examination. Oseltamivir was
withheld, his behavior became normal in the ward and he was
discharged the next day.
When age-matched controls with seasonal H1N1 or H3N2 who
did not receive oseltamivir were compared to the 49 children with
pH1N1 who did not receive oseltamivir, there was no difference in
underlying risk conditions or discharge diagnoses. Uncomplicated
URI accounted for 63%, 49% and 55% of the diagnoses in
children with pH1N1, seasonal H1N1 and H3N2, respectively.
(p=NS) Children with pH1N1 had a lower maximum temper-
ature recorded when compared to those with seasonal influenza
H3N2.
Pandemic Influenza Hospitalization in Children
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Disease manifestations seen in children hospitalized with pH1N1
in our patient population was mild. One Canadian study compared
58 children hospitalized with pH1N1 with 200 children infected
with seasonal influenza. [17] They found that those with pH1N1
with a median age of 6.6 years were significantly older than those
with seasonal influenza A with a median age of 3.3 years. Similar
proportions of children required intensive care admission and
intubationand the authorsconcludedthat pH1N1didnotappearto
cause more severe disease than seasonal influenza A.
There was no death or intensive care admission in any of the
hospitalized children in the 4 groups. Only half of the children
infected with pH1N1 were treated with oseltamivir. The general
recommendation at the time was to offer treatment to all children
hospitalized for pH1N1, but the final decision was still up to that of
the attending pediatrician in discussion with the parents.
Considering that uncomplicated upper respiratory tract infection
was the most common single diagnosis, the decision to not treat
mild disease is understandable. All except one pH1N1 patients
with pneumonia were given oseltamivir and 62.5% of children
with one or more high risk conditions were treated as well. The
recommendation for any child hospitalized for influenza has now
changed to that antiviral should be considered. [23]
In contrast to early reports in adults, gastrointestinal symptoms
were not prominent in our group of children hospitalized for
pH1N1, regardless of oseltamivir therapy.
Lymphopenia had been associated with pneumonia and respiratory
failure in adults. [2,24] Relative lymphopenia with or without increased
monocyte percentage has even been proposed as a surrogate marker of
pH1N1 and lymphopenia is thought by some to be uncommon in
children with influenza A. [25,26] However, lymphopenia ,1610
9/
ml was quite commonly seen in our children with uncomplicated
pH1N1 infection as well as in children with seasonal influenza.
A significant proportion of children with seasonal H1N1 and
H3N2 in years prior to the pandemic were discharged while still
febrile in our hospital, likely contributable to the availability of
rapid virus diagnosis which reassured parents and doctors of a
clinical diagnosis. We have previously shown that availability of
rapid virus diagnosis shortens the duration of hospitalization.[27]
However, children with pH1N1 and children with seasonal
influenza hospitalized during the pandemic period were signifi-
cantly less likely to be discharged while still febrile, presumably due
to a more conservative attitude of both health care workers and
parents during a pandemic with an increased reluctance to
discharge a child who was still febrile. This low proportion of
febrile children at discharge coupled with a lack of difference in
duration of fever before and during hospitalization between
pH1N1 and seasonal influenza A likely demonstrate that the total
duration of fever in children infected with pH1N1 may in fact be
shorter than those infected with seasonal influenza.
Up to the end of the study period, that is, as of September 27,
2009, 26,548 people in Hong Kong were virologically confirmed
to be infected. [28] Between May 1, 2009 and May 23, 2010, there
Table 1. Comparisons of pre-existing high risk conditions of children hospitalized for influenza A pH1N1 with age- matched
controls hospitalized for seasonal H1N1 and H3N2, and with children hospitalized for seasonal influenza concurrently during the
study period, respectively.
pH1N1 H1N1 H3N2 Concurrent pH1N1 pH1N1 pH1N1 pH1N1
(n=99) (n=99) (n=99) seasonal vs. vs. vs. (N=99)
influenza H1N1 H3N2 concurrent vs
(n=37) P value P value seasonal all influenza
influenza (N=235)
P value
$1 underlying 40 23 23 7 (18.9%) 0.0125 0.0171 0.032 0.0014
condition (40.4%) (23.2%) (23.2%)
Prematurity 5 4 7 0 NS NS NS NS
(5.1%) (4%) (7.1%)
Pulmonary 20 8 10 0 NS NS 0.007 NS
(20%) (8.1%) (10.1%)
Cardiac 2 3 1 3 (8.1%) NS NS NS NS
(2.0%) (3.0%) (1.0%)
Immunodeficiency 4 4 1 1 (2.7%) NS NS NS NS
(4.0%) (4.0%) (1.0%)
Malignancy 1 0 2 1 (2.7%) - NS NS NS
(1.0%) (2.0%)
Neurologic 10 5 7 2 (5.4%) NS NS NS NS
(10.1%) (5.1%) (7.1%)
Renal 2 2 1 0 NS NS NS NS
(2.0%) (1.1%) (1.0%)
Metabolic 2 1 1 1 (2.7%) NS NS NS NS
(2%) (0.5%) (0.5%)
doi:10.1371/journal.pone.0021837.t001
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to the Centre for Health Protection in Hong Kong. Children aged
below 10 years had the highest incidence rate of 2424 cases/
100,000 population. Seventeen percent of all laboratory-confirmed
cases required hospitalization and children below 5 years of age
accounted for 32.8% of these. Public hospitals (of which Queen
Mary Hospital is one) cater for 72.5% of general pediatric
hospitalizations and almost 100% of PICU hospitalizations in
Hong Kong. There has been in place a computerized medical
system of all the public hospitals for mandatory reporting of
Avian/pandemic influenza admissions (eFlu) since November
2005 and revised in July 2006 [29].Only 13 reports of serious
Table 2. Comparison of clinical diagnosis of children hospitalized for influenza A pH1N1 with age- matched controls hospitalized
for seasonal H1N1 and H3N2, and with children hospitalized for seasonal influenza concurrently during the study period,
respectively.
pH1N1 H1N1 H3N2 Concurrent pH1N1 pH1N1 pH1N1 vs. pH1N1
(N=99) (N=99) (N=99) seasonal vs. vs. concurrent (N=99)
influenza H1N1 H3N2 seasonal vs
(N=37) P value P value influenza all
P value influenza
(N=235)
Uncomplicated 54 50 52 27 NS NS NS NS
URI (54.5%) (50.5%) (52.5%) (73.0%)
Febrile seizure 6/44 10/44 13/44 4/23 NS NS NS NS
(6 months-5 (14.0%) (22.7%) (29.5%) (17.4%)
years)
Convulsion 11 12 10 1 NS NS NS NS
(11.1%) (12.1%) (10.1%) (2.7%)
Encephalopathy/ 1 1 0 0 NS - NS NS
encephalitis (1.0%) (1.0%)
Stroke 1 0 0 0 - - NS -
(1.0%)
Delirium/ 0 1 1 0 - - -
confusion (1.0%) (1.0%)
Syncope 1 1 2 0 NS - NS NS
(1.0%) (1.0%) (2.0%)
Pneumonia (all) 11 10 11 2 NS NS NS NS
(11.1%) (10.1) (11.1%) (5.4%)
Bacterial 5 0 3 0 - NS NS NS
pneumonia (5.1%) (3.0%)
Croup 2 3 1 0 NS NS NS NS
(2.0%) (3.0%) (1.0%)
Asthma 8 1 1 0 0.0455 0.0455 - 0.0014
exacerbation (8.1%) (1.0%) (1.0%)
Acute 0 1 3 0 - - - NS
bronchiolitis (1.0%) (3.0%)
Acute otitis 5 0 0 2 - - NS 0.0425
media (5.1%) (5.4%)
Tonsillitis/ 0 1 1 0 - - - -
pharyngitis (1.0%) (1.0%)
Gastroenteritis 1 6 2 1 NS NS NS NS
(1.0%) (6.1%) (2.0%) (2.7%)
Viral rash/ 0 1 2 0 - - - -
urticaria (1.0%) (2.0%)
Myositis 2 1 0 0 NS - NS NS
(2.0%) (1.0%)
doi:10.1371/journal.pone.0021837.t002
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months of the pandemic which included 11 PICU admissions.
There were only 3 pediatric death cases, 2 of these children had
cerebral palsy and one child had congenital heart disease in the
whole of Hong Kong SAR during that time. The manifestations of
pH1N1 in children appeared mild in Hong Kong, and the low
case fatality rate corroborated with the findings of this study.
There are strengths and limitations in this study. There is a
potential bias of using historical controls for comparison. However
this approach was chosen because it was important to age stratify
the patients for meaningful clinical comparisons. Using patients
with concurrent seasonal influenza does not provide an age
matched group for comparison and previous studies using
concurrent controls are open to criticism for this reason. Thus
we used both age matched historical controls as well as concurrent
controls with seasonal influenza for comparison. The observation
that pH1N1 is not clinically different to seasonal influenza is
supported by both age matched and concurrent control groups.
Another potential problem is that the threshold for admission may
be different during pandemic and inter-pandemic periods. There
might be potential bias for admission to include less severely
affected children during the pandemic period who would
otherwise not be admitted. This may be true to some extent in
Hong Kong as in other places, however, there was no death case
or ICU admission in any group in the study. Moreover, the study
period was chosen to avoid the period of attempted containment
when patients with pH1N1 were admitted for infection control
purposes, irrespective of clinical need. Over 80% of the children
admitted for pH1N1 were admitted through the Emergency
Department and diagnosed after admission. The study was
conducted over a short period but it included the period at which
pH1N1 peaked in late September and provided us with an
adequate number of patients for analysis.
In conclusion, using both age- matched patients with seasonal
influenza supplemented with concurrent admissions for seasonal
influenza, we demonstrated that children hospitalized for pH1N1
did not have more severe disease when compared to their controls
infected with seasonal H1N1 or H3N2, although they were more
Table 3. Comparison of duration of fever, investigation results and treatment of children hospitalized for influenza A pH1N1 with
age- matched controls hospitalized for seasonal H1N1 and H3N2, and with children hospitalized for seasonal influenza
concurrently during the study period, respectively.
pH1N1 H1N1 H3N2 Concurrent pH1N1 pH1N1 pH1N1 pH1N1
(N=99) (N=99) (N=99) Seasonal vs. vs. vs. (N=99)
Influenza H1N1 H3N2 concurrent vs
(N=37) P value P value seasonal all
influenza influenza
P value (N=235)
Mean days of 2.261.5 2.662.9 2.261.5 2.061.54 NS NS NS NS
fever at
presentation
Mean days of 3.761.8 4.163.1 3.962.0 3.761 . 5N SN SN S N S
fever before
discharge
% febrile at 9 (9.1%) 23 (23.2%) 21 (21.2%) 4 (10.8%) 0.0176 0.031 NS 0.0185
discharge
Mean Tmax 39.5160.59 39.7360.62 39.8560.66 39.7260.65 0.011 0.002 NS 0.0004
(
0C)
Mean days of 3.462.1 2.561.1 2.961.6 3.162.3 0.0002 NS NS NS
hospitalization
Abnormal 31/83 26/72 39/77 11/33 NS NS NS NS
CXR (44.6%) (36.1%) (50.6%) (33.3%)
Lymphocyte , 33/79 36/85 43/96 13/33 NS NS NS NS
1.0610
9/L (41.8%) (42.4%) (44.8%) (39.4%)
Neutrophil , 3/79 3/85 2/96 3/33 NS NS NS NS
1610
9/L (3.8%) (3.5%) (2.1%) (9.1%)
Neutrophil . 10/79 13/85 21/96 1/33 NS NS NS NS
8.3610
9/L (12.7%) (15.3%) (21.9%) (3.0%)
Full course of 50 (50.5%) 0 0 3 (8.1%) ,0.0001 ,0.0001 ,0.0001 ,0.0001
Oseltamivir
Full course of 18 (18.2%) 14 (14.1%) 13 (13.1%) 5 (13.5%) NS NS NS NS
antibiotic
doi:10.1371/journal.pone.0021837.t003
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influenza infection, a chronic pulmonary condition, more likely to
have asthma exacerbation and they were more likely to receive
oseltamivir, especially if they had pneumonia. Overall, disease
manifestations of children hospitalized for pH1N1 infection in our
patient population were mild.
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